CRB-701: "CRB-701 continues to be well tolerated with mainly grade 1 or 2 AEs"; Solid tumors (Corbus Pharmaceuticals) - Jun 5, 2024 - Corporate Presentation: "Still no DLTs or Grade 4 or 5 AEs observed to date including in the 4.5 mg/Kg cohort"
P1 data • Oncology • Solid Tumor
|